Mitochon Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Mitochon Pharmaceuticals has a total of 42 patents globally, out of which 15 have been granted. Of these 42 patents, more than 85% patents are active. The United States of America is where Mitochon Pharmaceuticals has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Mitochon Pharmaceuticals.

Mitochon Pharmaceuticals was founded in 2014. Mitochon Pharmaceuticals is a biotech start-up company focused on creating medications that target the mitochondria for a variety of critical illnesses with substantial unmet medical needs.

Do read about some of the most popular patents of Mitochon Pharmaceuticals which have been covered by us in this article and also you can find Mitochon Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Mitochon Pharmaceuticals patent portfolio.

How many patents does Mitochon Pharmaceuticals have?

Mitochon Pharmaceuticals has a total of 42 patents globally. These patents belong to 5 unique patent families. Out of 42 patents, 36 patents are active.

How Many Patents did Mitochon Pharmaceuticals File Every Year?

Mitochon Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantMitochon Pharmaceuticals Applications FiledMitochon Pharmaceuticals Patents Granted
202333
202245
202132
202012
201931
201831
2017141
201611

How many Mitochon Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Mitochon Pharmaceuticals Patent Portfolio

How Many Patents did Mitochon Pharmaceuticals File in Different Countries?

Mitochon Pharmaceuticals Worldwide Patent Filing

Countries in which Mitochon Pharmaceuticals Filed Patents

CountryPatent
United States Of America8
Japan6
China4
Australia4
Mexico4
Hong Kong (S.A.R.)3
Brazil2
Canada2
Europe2
Argentina1
Korea (South)1
Taiwan1

Where are Research Centers of Mitochon Pharmaceuticals Patents Located?

R&D Centres of Mitochon Pharmaceuticals

Best Mitochon Pharmaceuticals Patent

US9974755B2 is the most popular patent in the Mitochon Pharmaceuticals portfolio. It has received 7 citations so far from companies like Rivus Pharmaceuticals, Enzo Biochem and Cefo Co Ltd.

What Percentage of Mitochon Pharmaceuticals US Patent Applications Were Granted?

Mitochon Pharmaceuticals (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 100%.

Below are the key stats of Mitochon Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Mitochon Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Morgan Lewis & Bockius Llp3100%

List of Mitochon Pharmaceuticals patents

Mitochon Pharmaceuticals PatentsTitle
US11717497B2Induced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
US11406642B2Dnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss And/Or Metabolic Diseases
US10864173B2Induced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
US10548900B2Dnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss And/Or Metabolic Diseases
US10220006B2Induced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
US9974755B2Induced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
US9763896B2Induced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
US20230100940A1Dnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss And/Or Metabolic Diseases
EP3247340B1Induced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular And/Or Neurodegenerative Diseases
EP3426233A4Dnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Concussion, Dry Eye Disease, And/Or Metabolic Diseases
CN116617195AInducible Expression Of Brain-Derived Neurotrophic Factor
CN115227685ADnp And Dnp Prodrug Therapy Of Diseases
CN109195589ADnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Concussion, Dry Eye Disease, And/Or Metabolic Diseases
WO2023205625A22,4 Dnp And Prodrugs Thereof For Treatment Of Pulmonary And Autoimmune Diseases
WO2023014882A12,4 Dnp And Prodrugs Thereof For Treatment Of Cancer
TWI794161BDnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss, And/Or Metabolic Diseases
JP7021098B2Dnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease And/Or Metabolic Disease
JP6951976B2Induced Expression Of Brain-Derived Neurotrophic Factor (Bdnf) For The Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
JP2023016939ADnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease And/Or Metabolic Diseases
JP2022173519AInduced Expression Of Brain-Derived Neurotrophic Factor (Bdnf) For The Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
JP2021165319ADnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease And/Or Metabolic Disease
AU2017229224B2Dnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Concussion, Dry Eye Disease, And/Or Metabolic Diseases
AU2016209255B2Induced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
AU2021240120A1Induced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
CA3016465A1Dnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss, And/Or Metabolic Diseases
CA2974092A1Induced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
KR1020170104597AInduced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
MX396623BTreatment Of Dinitrophenol (Dnp) And Dinitrophenol Prodrug (Dnp) For Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Shock, Dry Eye And/Or Metabolic Diseases.
MX392410BInduced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For The Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases.
HK40082341ADnp And Dnp Prodrug Treatment Of Diseases
MX2022009725ADnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Concussion, Dry Eye Disease, And/Or Metabolic Diseases.
MX2022005937AInduced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases.
HK40002415ADnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Concussion, Dry Eye Disease, And/Or Metabolic Diseases
BR112018067966A2Treatment With Dnp And Dnp Pro-Drug Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Concussion, Dry Eye Disease, And/Or Metabolic Diseases
HK1247101AInduced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
AR107818A1Treatment With Dinitrophenol And Dinitrophenol Prodro-Gas Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injuries, Concussion, Dry Eye, Hearing Loss And/Or Metabolic Diseases
CN107405315AInduced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
WO2017155940A1Dnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Concussion, Dry Eye Disease, And/Or Metabolic Diseases
WO2016118741A1Induced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
JP2021080286AInduced Expression Of Brain Derived Neurotrophic Factor (Bdnf) For Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases
AU2023200805A1Dnp And Dnp Prodrug Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental, Traumatic Brain Injury, Concussion, Dry Eye Disease, Hearing Loss, And/Or Metabolic Diseases
BR112017015721A2Induced Expression Of Brain-Derived Neurotrophic Factor (Bdnf) For The Treatment Of Neuromuscular, Neurodegenerative, Autoimmune, Developmental And/Or Metabolic Diseases.

What are Mitochon Pharmaceuticals key innovation segments?

What Technologies are Covered by Mitochon Pharmaceuticals?

The chart below distributes patents filed by Mitochon Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Mitochon Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Mitochon Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Mitochon Pharmaceuticals?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.